Clinical Trial Update: Baclofen for Smoking Cessation in a Non-Psychiatric Population [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating baclofen for smoking cessation in nicotine dependence was terminated; the update provides the trial status without reported results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Nicotine Dependence | Phase 2 | Status: TERMINATED